ATE319136T1 - Verfahren zum screenen und herstellen von verbindungsbibliotheken - Google Patents

Verfahren zum screenen und herstellen von verbindungsbibliotheken

Info

Publication number
ATE319136T1
ATE319136T1 AT99948226T AT99948226T ATE319136T1 AT E319136 T1 ATE319136 T1 AT E319136T1 AT 99948226 T AT99948226 T AT 99948226T AT 99948226 T AT99948226 T AT 99948226T AT E319136 T1 ATE319136 T1 AT E319136T1
Authority
AT
Austria
Prior art keywords
absorption
compound library
screening
test samples
libraries
Prior art date
Application number
AT99948226T
Other languages
English (en)
Inventor
George M Grass
Glen D Leesman
Daniel A Norris
Patrick J Sinko
John E Wehrli
Original Assignee
Lion Bioscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Bioscience Ag filed Critical Lion Bioscience Ag
Application granted granted Critical
Publication of ATE319136T1 publication Critical patent/ATE319136T1/de

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry
    • G16C20/62—Design of libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Computing Systems (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Library & Information Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99948226T 1998-09-14 1999-09-14 Verfahren zum screenen und herstellen von verbindungsbibliotheken ATE319136T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US10022498P 1998-09-14 1998-09-14
US10029098P 1998-09-14 1998-09-14
US10923298P 1998-11-18 1998-11-18
US10923498P 1998-11-18 1998-11-18
US32006999A 1999-05-26 1999-05-26
US09/320,544 US20020010550A1 (en) 1998-09-14 1999-05-26 Pharmacokinetic-based drug design tool and method
US09/320,270 US20020035459A1 (en) 1998-09-14 1999-05-26 Pharmacokinetic-based drug design tool and method
US09/320,545 US6542858B1 (en) 1998-09-14 1999-05-26 Pharmacokinetic-based drug design tool and method
US09/320,372 US20010041964A1 (en) 1998-09-14 1999-05-26 Pharmacokinetic-based drug design tool and method
US09/320,371 US6647358B2 (en) 1998-09-14 1999-05-26 Pharmacokinetic-based drug design tool and method

Publications (1)

Publication Number Publication Date
ATE319136T1 true ATE319136T1 (de) 2006-03-15

Family

ID=27536966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99948226T ATE319136T1 (de) 1998-09-14 1999-09-14 Verfahren zum screenen und herstellen von verbindungsbibliotheken

Country Status (8)

Country Link
US (6) US20020010550A1 (de)
EP (2) EP1185948B1 (de)
JP (2) JP2003521673A (de)
AT (1) ATE319136T1 (de)
AU (2) AU767944B2 (de)
CA (2) CA2343914A1 (de)
DE (1) DE69930137D1 (de)
WO (2) WO2000015178A2 (de)

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010487A6 (nl) * 1996-06-11 1998-10-06 Unilin Beheer Bv Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
US20040117125A1 (en) * 1999-04-26 2004-06-17 Hao Chen Drug discovery method and apparatus
US7759113B2 (en) * 1999-04-30 2010-07-20 The General Hospital Corporation Fabrication of tissue lamina using microfabricated two-dimensional molds
US20070020662A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
US20050089923A9 (en) * 2000-01-07 2005-04-28 Levinson Douglas A. Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds
US20070021929A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
US7216113B1 (en) * 2000-03-24 2007-05-08 Symyx Technologies, Inc. Remote Execution of Materials Library Designs
US7776021B2 (en) * 2000-04-28 2010-08-17 The Charles Stark Draper Laboratory Micromachined bilayer unit for filtration of small molecules
US6549803B1 (en) * 2000-05-08 2003-04-15 Image-Guided Neurologics Inc. Method and apparatus for targeting material delivery to tissue
JP2004514879A (ja) * 2000-07-28 2004-05-20 ライオン　バイオサイエンス　アクチェンゲゼルシャフト 哺乳類における化合物の代謝を予測するための薬物動態ツールおよび方法
US7319945B1 (en) * 2000-11-10 2008-01-15 California Institute Of Technology Automated methods for simulating a biological network
US7043415B1 (en) * 2001-01-31 2006-05-09 Pharsight Corporation Interactive graphical environment for drug model generation
US6937257B1 (en) * 2001-01-31 2005-08-30 Pharsight Corporation Unit tracking and notification in a graphical drug model editor
US20020111850A1 (en) * 2001-02-12 2002-08-15 Chevron Oronite Company Llc System and method for new product clearance and development
US6631291B2 (en) * 2001-05-18 2003-10-07 Instrumentarium Corp. Closed loop drug administration method and apparatus using EEG complexity for control purposes
CA2457408A1 (en) * 2001-07-13 2003-01-23 Pharmacopeia, Inc. System and method for aqueous solubility prediction
DE10142019A1 (de) * 2001-08-28 2003-03-20 Philips Corp Intellectual Pty Schaltungsanordnung zur Demodulation von Signalen
CA2496143A1 (en) * 2001-10-12 2003-04-17 University Of Utah Research Foundation Anesthesia drug monitor
US7027970B2 (en) * 2001-10-19 2006-04-11 Globomax Llc Tool for in vitro-in vivo correlation
US20030078760A1 (en) * 2001-10-19 2003-04-24 Globomax Holdings, Llc Population pharmacokinetic modeling and analysis (PDx-POP™)
US7415359B2 (en) * 2001-11-02 2008-08-19 Gene Network Sciences, Inc. Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents
US6799123B2 (en) * 2001-11-05 2004-09-28 Lyn Hughes Dissolution test equipment and method
DE10160270A1 (de) * 2001-12-07 2003-06-26 Bayer Ag Computersystem und Verfahren zur Berechnung von ADME-Eigenschaften
AU2003217912A1 (en) * 2002-03-01 2003-09-16 Xencor Antibody optimization
EP1490520A4 (de) * 2002-03-12 2006-06-07 Surface Logix Inc Testvorrichtung, die die absorption, den stoffwechsel, die permeabiltät und/oder toxizität einer kandidatenverbindung analysiert
JP2005529158A (ja) * 2002-05-28 2005-09-29 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 両親媒性ポリマーのコンピュータ分析および設計のための方法、システムおよびコンピュータプログラム製品
ATE360015T1 (de) * 2002-07-31 2007-05-15 Critical Outcome Technologies Protein tyrosin kinase inhibitoren
AU2003269395A1 (en) * 2002-09-16 2004-04-30 Optimata, Ltd. An interactive technique for optimizing drug development from the pre-clinical phases through phase-iv
ATE380810T1 (de) * 2002-10-09 2007-12-15 Critical Outcome Technologies Protein-tyrosine-kinase-inhibitoren
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
DE10256315A1 (de) 2002-12-03 2004-06-17 Bayer Ag Computersystem und Verfahren zur Berechnung eines pharmakokinetischen Verhaltens einer chemischen Substanz in Insekten
EP1589814B1 (de) 2003-01-16 2009-08-12 The General Hospital Corporation Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
US20040220785A1 (en) * 2003-01-21 2004-11-04 Van Osdol William W. Computational model for transdermal drug delivery
WO2005034624A2 (en) 2003-05-21 2005-04-21 The General Hospital Corporation Microfabricated compositions and processes for engineering tissues containing multiple cell types
US7853406B2 (en) * 2003-06-13 2010-12-14 Entelos, Inc. Predictive toxicology for biological systems
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
US8346482B2 (en) 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
DE10345836A1 (de) * 2003-10-02 2005-04-21 Bayer Technology Services Gmbh Verfahren zur Simulation der Wechselwirkung von chemischen Substanzen mit lebenden Organismen
JP4247101B2 (ja) * 2003-12-10 2009-04-02 株式会社東芝 設計支援システム
JP2005245667A (ja) * 2004-03-03 2005-09-15 Koninkl Philips Electronics Nv 薬剤投与設計システム
EP1747535A2 (de) * 2004-05-10 2007-01-31 Philips Intellectual Property & Standards GmbH Bilddatenverarbeitungssystem für die abteilungsanalyse
DE102004025534A1 (de) * 2004-05-25 2005-12-15 Bayer Technology Services Gmbh Verfahren zur (zweistufigen) Dosis- und Dosierungsfindung
WO2005116647A2 (en) * 2004-05-28 2005-12-08 Philips Intellectual Property & Standards Gmbh System for the evaluation of tracer concentration in a reference tissue and a target region
WO2005116902A2 (en) * 2004-05-28 2005-12-08 Philips Intellectual Property & Standards Gmbh System for the noninvasive determination of tracer concentration in blood
US20050278124A1 (en) * 2004-06-14 2005-12-15 Duffy Nigel P Methods for molecular property modeling using virtual data
US20060052943A1 (en) * 2004-07-28 2006-03-09 Karthik Ramani Architectures, queries, data stores, and interfaces for proteins and drug molecules
US8396670B2 (en) * 2004-08-16 2013-03-12 Venture Milling, Inc. Process, system and method for improving the determination of digestive effects upon an ingestable substance
WO2006060214A2 (en) * 2004-11-18 2006-06-08 The Regents Of The University Of California Apparatus and methods for manipulation and optimization of biological systems
HUE034171T2 (en) 2004-11-24 2018-02-28 Bayer Healthcare Llc Tools, systems and procedures for fluid transfer
US20060195308A1 (en) * 2004-12-16 2006-08-31 Entelos, Inc. Methods and models for cholesterol metabolism
GB2439032B (en) * 2005-04-15 2010-10-20 Thermo Crs Ltd Method and system for sample testing
WO2006119325A2 (en) * 2005-05-02 2006-11-09 Plectix Biosystems, Inc. Using biological models
US7331251B2 (en) * 2005-06-22 2008-02-19 Idaho State University Dissolution testing of solid dosage forms intended to be administered in the oral cavity
US20080111066A1 (en) * 2005-08-31 2008-05-15 Jing Jim Zhang Derivatization and low level detection of drugs in biological fluid and other solution matrices using a proxy marker
EP1955190B1 (de) 2005-11-10 2018-08-29 In Silico Biosciences, Inc. Verfahren und vorrichtung zur computermodellierung des menschlichen gehirns zur vorhersage von medikamenteneffekten
DE102005061270A1 (de) * 2005-12-20 2007-06-28 Universität Hamburg Screening-Verfahren
EP1884878A1 (de) * 2006-08-02 2008-02-06 Hitachi Ltd. Computersystem zur Simulation eines physikalischen Systems
WO2008046045A1 (en) * 2006-10-12 2008-04-17 Cylene Pharmaceuticals, Inc. Drug biovailability screens
KR100856517B1 (ko) 2007-01-03 2008-09-04 주식회사 인실리코텍 수학적 모델을 이용한 펩타이드 서열의 조직 표적 예측시스템 및 방법과 그 프로그램을 저장한 기록매체
WO2008085421A2 (en) 2006-12-29 2008-07-17 Medrad, Inc. Patient-based parameter generation systems for medical injection procedures
CA2673683C (en) 2007-01-11 2014-07-29 Critical Outcome Technologies, Inc. Compounds and method for treatment of cancer
MX2009010534A (es) * 2007-03-30 2009-12-01 9898 Ltd Tecnologia de plataforma farmaceutica para el desarollo de productos naturales.
US8718944B2 (en) * 2007-05-22 2014-05-06 Worcester Polytechnic Institute Patient-specific image-based computational modeling and techniques for human heart surgery optimization
US20090037539A1 (en) * 2007-08-02 2009-02-05 Telefonaktiebolaget Lm Ericsson (Publ) Methods and Systems for Message Interworking
US8738116B2 (en) * 2007-09-21 2014-05-27 National Research Council Of Canada Method and apparatus for periodontal diagnosis
CA2710039C (en) 2007-12-26 2018-07-03 Critical Outcome Technologies, Inc. Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer
CA2710333A1 (en) * 2008-01-03 2009-07-09 Abbott Biotechnology Ltd. Predicting long-term efficacy of a compound in the treatment of psoriasis
CA2758393A1 (en) * 2008-04-18 2009-10-22 The University Of Manchester Imaging technique
US20100004762A1 (en) * 2008-04-24 2010-01-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US9449150B2 (en) * 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100280332A1 (en) * 2008-04-24 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring bioactive agent use
US7974787B2 (en) 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US20100022820A1 (en) * 2008-04-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20090271122A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US9560967B2 (en) * 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US8876688B2 (en) 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US20100030089A1 (en) * 2008-04-24 2010-02-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US20090312668A1 (en) * 2008-04-24 2009-12-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20090271375A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Combination treatment selection methods and systems
US9649469B2 (en) * 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9064036B2 (en) * 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US20100076249A1 (en) * 2008-04-24 2010-03-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20090271347A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring bioactive agent use
US20100100036A1 (en) * 2008-04-24 2010-04-22 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational System and Method for Memory Modification
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US20100041958A1 (en) * 2008-04-24 2010-02-18 Searete Llc Computational system and method for memory modification
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US20100042578A1 (en) * 2008-04-24 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20090270694A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US9662391B2 (en) * 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US8606592B2 (en) 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US20090271009A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Combination treatment modification methods and systems
US20100015583A1 (en) * 2008-04-24 2010-01-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational System and method for memory modification
US20090269329A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Combination Therapeutic products and systems
US20090270688A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting a combination treatment
US20100081861A1 (en) * 2008-04-24 2010-04-01 Searete Llc Computational System and Method for Memory Modification
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US7801686B2 (en) * 2008-04-24 2010-09-21 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US20100017001A1 (en) * 2008-04-24 2010-01-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20100041964A1 (en) * 2008-04-24 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US20100125561A1 (en) * 2008-04-24 2010-05-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US9239906B2 (en) * 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100081860A1 (en) * 2008-04-24 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational System and Method for Memory Modification
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
KR100946145B1 (ko) * 2008-05-13 2010-03-08 성균관대학교산학협력단 서열 유사도 측정 장치 및 그 제어방법
CA2730890C (en) 2008-07-17 2018-05-15 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
WO2010048532A1 (en) * 2008-10-24 2010-04-29 Amicus Therapeutics, Inc. Multiple compartment dosing model
US20100163038A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8694330B2 (en) * 2008-12-30 2014-04-08 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100169260A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100168602A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100163027A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100168525A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163033A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100166613A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100168529A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8706518B2 (en) * 2008-12-30 2014-04-22 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US8725529B2 (en) * 2008-12-30 2014-05-13 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100169259A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8712794B2 (en) * 2008-12-30 2014-04-29 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163034A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163036A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163024A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Methods and systems for presenting an inhalation experience
US8738395B2 (en) * 2008-12-30 2014-05-27 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163025A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
WO2010138967A2 (en) 2009-05-29 2010-12-02 Wesolowski Carl A Method for evaluating renal function
CN105808956A (zh) 2009-10-19 2016-07-27 提拉诺斯公司 集成的健康数据采集和分析系统
CA2794952C (en) 2010-04-01 2018-05-15 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv
KR101298303B1 (ko) * 2010-04-27 2013-08-20 울산대학교 산학협력단 약물의 약동-약력학적 모델링을 위한 통합 분석 시스템
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
JP6025718B2 (ja) * 2010-06-24 2016-11-16 ベイヤー メディカル ケア インク． 注入プロトコルのための医薬品の伝播およびパラメータ生成のモデル
EP2609209B1 (de) * 2010-08-25 2025-06-25 Optibrium Ltd Auswahl von verbindungen in der wirkstoffforschung
DE102010060311B3 (de) * 2010-11-02 2012-02-02 Freie Universität Berlin Verfahren zur Unterstützung klinischer Studien
JP6078473B2 (ja) 2010-12-15 2017-02-08 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 輪郭によりガイドされる変形画像レジストレーション
CN103077296B (zh) * 2011-10-25 2015-11-18 复旦大学附属华山医院 基于流速调节的静脉注射药动学模型的体外模拟方法
DE102011085180A1 (de) * 2011-10-25 2013-04-25 Piramal Imaging Sa Verfahren zur Erzeugung optimierter Tomografie-Aufnahmen
CN102682209B (zh) * 2012-05-03 2014-11-05 桂林理工大学 有机污染物定量结构活性相关建模的变量筛选方法
EP2850418B1 (de) 2012-05-14 2019-02-20 Bayer Healthcare LLC Systeme und verfahren zur festlegung von protokollen über injektionen einer pharmazeutischen flüssigkeit auf basis einer röntgenröhrenspannung
WO2014020428A2 (en) * 2012-08-02 2014-02-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method and computing system for modelling a primate brain
US20160335412A1 (en) * 2013-01-30 2016-11-17 Geoffrey Tucker Systems and methods for predicting and adjusting the dosage of medicines in individual patients
US20150147738A1 (en) * 2013-03-13 2015-05-28 Bowling Green State University Methods and systems for teaching biological pathways
WO2017180807A1 (en) 2016-04-15 2017-10-19 Baxalta Incorporated Method and apparatus for providing a pharmacokinetic drug dosing regiment
WO2015017798A2 (en) 2013-08-02 2015-02-05 CRIXlabs, Inc. Method and system for predicting spatial and temporal distributions of therapeutic substance carriers
EP2911075A1 (de) * 2014-02-25 2015-08-26 LTS LOHMANN Therapie-Systeme AG System zur Bestimmung einer Eignung eines Wirkstoffs für die transdermale oder transmukosale Applikation sowie entsprechendes Verfahren
TW201618795A (zh) * 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
EP3712254A1 (de) 2014-05-28 2020-09-23 Children's Hospital Medical Center Verfahren und systeme zur umwandlung von vorläuferzellen in magengewebe durch gezielte differenzierung
CA2963704A1 (en) 2014-10-17 2016-04-21 Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
WO2016133373A1 (ko) 2015-02-17 2016-08-25 싸이퍼롬, 인코퍼레이티드 항암제 부작용 방지를 위한 개인별 단백질 손상 정보 기반의 항암제 선택 방법
CA2976320C (en) * 2015-07-29 2019-02-19 Synaptive Medical (Barbados) Inc. Method, system and apparatus for adjusting image data to compensate for modality-induced distortion
EP4177335A1 (de) 2016-05-05 2023-05-10 Children's Hospital Medical Center Verfahren zur in-vitro-herstellung von magenfundusgewebe und zusammensetzungen im zusammenhang damit
US11478125B2 (en) 2016-06-30 2022-10-25 Given Imaging Ltd. Systems and methods for assessment and monitoring of a mucosal disease in a subjects gastrointestinal tract
SG11201903697WA (en) 2016-11-04 2019-05-30 Childrens Hospital Med Ct Liver organoid compositions and methods of making and using same
EP3548507A4 (de) 2016-12-05 2020-07-15 Children's Hospital Medical Center Kolonorganoide und verfahren zur herstellung und verwendung davon
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
EP3609997A4 (de) 2017-04-14 2021-03-03 Children's Hospital Medical Center Multidonor-stammzellenzusammensetzungen und verfahren zu ihrer herstellung
US12297457B2 (en) 2017-10-10 2025-05-13 Children's Hospital Medical Center Esophageal tissue and/or organoid compositions and methods of making same
WO2019104101A1 (en) * 2017-11-21 2019-05-31 Verisim Life Inc. Systems and methods for full body circulation and drug concentration prediction
EP3727394A4 (de) 2017-12-21 2021-09-08 Children's Hospital Medical Center Digitalisierte menschliche organoide und verfahren zu deren verwendung
US11468973B2 (en) * 2018-02-02 2022-10-11 Richard Postrel Leveraging genomic, phenotypic and pharmacological data to cure disease
US20210183467A1 (en) * 2018-07-03 2021-06-17 Yale University System and method for using microbiome to de-risk drug development
US12421500B2 (en) 2018-07-26 2025-09-23 Children's Hospital Medical Center Hepato-biliary-pancreatic tissues and methods of making same
JP2021535753A (ja) 2018-09-12 2021-12-23 チルドレンズ ホスピタル メディカル センター 造血幹細胞およびその派生体の生成のためのオルガノイド組成物
US12191003B2 (en) 2018-10-01 2025-01-07 International Business Machines Corporation Real-time prediction of chemical properties through combining calculated, structured and unstructured data at large scale
US11580275B1 (en) * 2018-12-18 2023-02-14 X Development Llc Experimental discovery processes
EP3683800A1 (de) * 2019-01-18 2020-07-22 Tata Consultancy Services Limited Verfahren und system für insilico-design und prüfung von formulierungen unter verwendung eines physiochemischen hautmodells
WO2020160371A1 (en) 2019-02-01 2020-08-06 The University Of Hong Kong Innervated organoid compositions and methods of making same
CA3141814A1 (en) 2019-05-31 2020-12-03 Children's Hospital Medical Center Shaped organoid compositions and methods of making same
CN114174494A (zh) 2019-05-31 2022-03-11 儿童医院医学中心 产生和扩增造血干细胞的方法
US10515715B1 (en) 2019-06-25 2019-12-24 Colgate-Palmolive Company Systems and methods for evaluating compositions
US12100515B2 (en) 2019-07-11 2024-09-24 International Business Machines Corporation Altering a targeted brain therapeutic based on a brain circuit model
JP2022541122A (ja) * 2019-07-17 2022-09-22 ビーエーエスエフ ソシエタス・ヨーロピア 製品開発を支援するためのデジタルアシスタント
EP3786962B1 (de) * 2019-07-19 2025-09-17 Tata Consultancy Services Limited Systeme und verfahren zur erzeugung eines optimierten satzes von pharmakokinetischen (pk) und pharmakodynamischen (pd) parametern
CN110766084B (zh) * 2019-10-28 2021-06-15 北京理工大学 基于cae与hl-cnn的小样本sar目标识别方法
US20220044829A1 (en) * 2020-08-07 2022-02-10 Cipherome, Inc. Interactive user interface for providing treatment information
US20240062131A1 (en) * 2020-12-23 2024-02-22 Basf Se Data Driven Multi-Criteria Optimization of Chemical Formulations
JP7302621B2 (ja) * 2021-04-02 2023-07-04 株式会社豊田中央研究所 有機材料輸送特性評価装置及び有機材料輸送特性評価方法
WO2022244022A1 (en) * 2021-05-21 2022-11-24 Aizen Algo Private Limited Method and system for prediction of time points in pharmacokinetic studies
WO2022248703A2 (en) 2021-05-27 2022-12-01 Cyprus University Of Technology Physiologically based toxicokinetic (pbtk) modeling for implant toxicology
CN121191683B (zh) * 2025-09-25 2026-04-17 中国人民解放军总医院第五医学中心 一种抗辐射药物剂量数据采集自适应剂量控制系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335438A (en) 1980-04-17 1982-06-15 Smolen Victor F Method and apparatus for automatic dissolution testing of products
US4411989A (en) 1981-08-13 1983-10-25 Midwest Research Institute Processes and devices for detection of substances such as enzyme inhibitors
GB2206429A (en) 1987-07-02 1989-01-05 Infrared Eng System determining properties or identity of a sample
US4775794A (en) 1987-11-02 1988-10-04 Zenon Environmental Inc. Process and apparatus for measurement of light-absorbable components dissolved in liquids
US4975581A (en) 1989-06-21 1990-12-04 University Of New Mexico Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids
US5723289A (en) 1990-06-11 1998-03-03 Nexstar Pharmaceuticals, Inc. Parallel selex
US5680590A (en) 1990-09-21 1997-10-21 Parti; Michael Simulation system and method of using same
US5331573A (en) 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
US5387421A (en) 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5326778A (en) * 1992-03-03 1994-07-05 Research Corporation Technologies, Inc. Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
EP0695174B1 (de) 1993-04-20 2003-03-19 TSRL, Inc. Mehrstufiges arzneistoffabgabesystem
US5703792A (en) 1993-05-21 1997-12-30 Arris Pharmaceutical Corporation Three dimensional measurement of molecular diversity
US5569452A (en) 1993-08-31 1996-10-29 Tsrl, Inc. Pharmaceutical formulation having enhanced bile acid binding affinity
JPH09505603A (ja) 1993-11-26 1997-06-03 ヘンドリー，ローレンス，ビー． レセプター−リガンド−ｄｎａ相互作用に係わる薬剤の設計
WO1995019359A1 (en) * 1994-01-12 1995-07-20 Massachusetts Institute Of Technology Process for making xanthene or cubane based compounds, and protease inhibitors
US5625579A (en) 1994-05-10 1997-04-29 International Business Machines Corporation Stochastic simulation method for processes containing equilibrium steps
CA2203886C (en) 1994-10-28 2003-09-02 Soren-Peter Olesen Patch clamp apparatus and technique having high throughput and low fluid volume requirements
US5792833A (en) 1994-12-22 1998-08-11 New England Medical Center Hospitals, Inc. E2 binding proteins
US5914891A (en) 1995-01-20 1999-06-22 Board Of Trustees, The Leland Stanford Junior University System and method for simulating operation of biochemical systems
US5699268A (en) 1995-03-24 1997-12-16 University Of Guelph Computational method for designing chemical structures having common functional characteristics
US5657255C1 (en) 1995-04-14 2002-06-11 Interleukin Genetics Inc Hierarchic biological modelling system and method
AU7525996A (en) 1995-11-03 1997-05-22 Eli Lilly And Company Automated permeability analysis system
WO1997020952A1 (en) 1995-12-07 1997-06-12 Scriptgen Pharmaceuticals, Inc. A fluorescence-based screening method for identifying ligands
US5783397A (en) 1995-12-11 1998-07-21 Northeastern University Screening natural samples for new therapeutic compounds using capillary electrophoresis
WO1997029091A1 (en) 1996-02-09 1997-08-14 Phytera Symbion Aps Balanol analogues
US5880972A (en) 1996-02-26 1999-03-09 Pharmacopeia, Inc. Method and apparatus for generating and representing combinatorial chemistry libraries
CA2258279A1 (en) 1996-06-27 1997-12-31 Peter J. Dehlinger High-throughput screening method and apparatus
CA2258489C (en) 1996-06-28 2004-01-27 Caliper Technologies Corporation High-throughput screening assay systems in microscale fluidic devices
EP0818744A3 (de) 1996-07-08 1998-07-08 Proteus Molecular Design Limited Verfahren zur Auswahl von Kandidat-Drogenverbindungen
AU4330997A (en) 1996-08-29 1998-03-19 Chiron Corporation Method for analysing absorption, distribution, metabolism, excretion (ADME) an d pharmacokinetics properties of compound mixtures
US5854992A (en) 1996-09-26 1998-12-29 President And Fellows Of Harvard College System and method for structure-based drug design that includes accurate prediction of binding free energy
EP0958293B1 (de) 1997-02-04 2005-01-19 The Regents Of The University Of California Nanomolare, non-peptidische inhibitoren von cathepsin d
EP0918296A1 (de) 1997-11-04 1999-05-26 Cerep Verfahren zum virtuellen Wiederauffinden von Analogen von Bleiverbindungen durch Erzeugen von potentiellen Bibliotheken

Also Published As

Publication number Publication date
US20020010550A1 (en) 2002-01-24
US20020013662A1 (en) 2002-01-31
JP2003521673A (ja) 2003-07-15
US6542858B1 (en) 2003-04-01
AU768368B2 (en) 2003-12-11
US20010041964A1 (en) 2001-11-15
EP1144675A4 (de) 2007-05-02
JP2002524809A (ja) 2002-08-06
US6647358B2 (en) 2003-11-11
WO2000015178A3 (en) 2001-07-26
CA2344036A1 (en) 2000-03-23
US20020061540A1 (en) 2002-05-23
EP1185948A1 (de) 2002-03-13
EP1185948A4 (de) 2002-06-26
WO2000016231A1 (en) 2000-03-23
US20020035459A1 (en) 2002-03-21
EP1144675A2 (de) 2001-10-17
WO2000015178A2 (en) 2000-03-23
DE69930137D1 (de) 2006-04-27
AU6145199A (en) 2000-04-03
CA2343914A1 (en) 2000-03-23
WO2000015178A9 (en) 2001-10-04
US6996473B2 (en) 2006-02-07
EP1185948B1 (de) 2006-03-01
AU767944B2 (en) 2003-11-27
AU6247499A (en) 2000-04-03

Similar Documents

Publication Publication Date Title
DE69930137D1 (de) Verfahren zum screenen und herstellen von verbindungsbibliotheken
DE69401810D1 (de) Verfahren zu reinigung von taxol derivate
DK38994A (da) Fremgangsmåde og apparat til at lokalisere og genindføre en eller flere vandrette brønde ved hjælp af dornorganer
DZ2310A1 (fr) Procédé sismique à source vibratrice haute fidélité.
NO833131L (no) Fremgangsmaate og apparat for undersoekelse av egenskaper ved grunnformasjon som omgir et borehull
DE69112994D1 (de) Verfahren zur interaktionalen selbstmodelierenden analyse von gemischen.
FI913404A7 (fi) Menetelmä ja laite kaasun erottamiseksi kaasupitoisesta materiaalista
DE58903466D1 (de) Sonde zur entnahme von aggressiven gasen aus kanaelen, insbesondere rauchgaskanaelen.
FI962371A7 (fi) Menetelmä kombinatoristen yhdistekirjastojen valmistamiseksi
DE69923278D1 (de) Verfahren zum herstellen von zusammenhängenden beuteln
NO974949D0 (no) Aktiveringsmiddel for boreapparat (magnetisk)
IT1243206B (it) Apparecchio di vagliatura per analisi granulometrica
DE3869301D1 (de) Methode zum reinigen von giftige komponenten enthaltendem gas.
NO980493D0 (no) Fremgangsmåte for behandling av orienterte seismiske flerkomponentdata fra en brönn
DK0734461T3 (da) Anvendelse af et apparat til dannelse af exciteret gas
NO20006244D0 (no) Rettet kombinatorisk forbindelse-bibliotek og analyser med höyt utbytte for screening derav
DK389689D0 (da) Fremgangsmaade til adskillelse af dampformige tung metalforbindelser fra en baeregas og apparat til gennemfoerelse af fremgangsmaaden
FI910431A0 (fi) Foerfarande foer raffinering av blandningar som erhaollits genom behandling av fetthaltiga media med cyklodextrin och som innehaoller komplex av cyklodextrin med lipofila foereningar.
FI844444A7 (fi) Menetelmä näyteaineen analysoimiseksi fotoakustisella tai optotermisellä spektroskoopilla ja näytteenkantajamenetelmän suorittamiseksi.
DE69026328D1 (de) Verfahren zum Screenen von Arzneimitteln
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
FI895817A0 (fi) Menetelmä (ko)polymeerien modifioimiseksi
GB9003265D0 (en) Process for the mass-spectroscopic investigation of isotopes,as well as isotope mass spectrometer
FI980781A7 (fi) Menetelmä ja laite kaasuseosten analysoimiseksi
FI913371A7 (fi) Menetelmä ja laite näytteen ottamiseksi nesteestä, joka sisältää liuot ettua kaasua

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties